Gut and liver symptoms in multiple sclerosis patients
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at stomach, intestine, and liver symptoms in people with multiple sclerosis (MS) who are on treatment. It aims to understand how common these symptoms are and why they happen, which could help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple sclerosis (MS) using the 2017 McDonald criteria
- You are currently on a disease-modifying therapy (DMT) for MS
- You have stomach, intestine, or liver symptoms that are not explained by another known cause (like hepatitis, Wilson disease, hemochromatosis, drug side effects, or alcohol)
- You are 18 years old or older
- You are willing to sign a consent form and attend follow-up visits and MRI scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether following a Mediterranean diet can improve quality of life for people with multiple sclerosis (MS). It aims to find a dietary approach that may help manage symptoms and improve well-being.
This study looks at adults who have known or possible problems in the digestive system or liver. It may help patients by offering structured evaluation and follow-up for their condition.
This study looks at the bacteria in your gut (microbiome) and how your body responds to liver disease. Researchers want to learn if these factors can help improve care for people with liver problems.
This study looks at how gut bacteria differ in people with specific liver diseases and their household contacts. It may help researchers understand the connection between the liver and gut.
This study tests whether a ketogenic diet can help people with multiple sclerosis. You would follow a special high-fat, low-carb diet for a period, and the researchers will check its effects on your symptoms and overall health.
This study looks at the bacteria naturally living in your gut (the microbiome) to better understand liver cirrhosis. It does not test a new drug or treatment, only collects information and samples.
Hear when a new MS (Multiple Sclerosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.